Therapeutic angiogenesis in cardiovascular disease
Top Cited Papers
- 1 November 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (11) , 863-872
- https://doi.org/10.1038/nrd1226
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial IschemiaCirculation, 2003
- The VIVA TrialCirculation, 2003
- Regulation and Destabilization of HIF-1α by ARD1-Mediated AcetylationCell, 2002
- Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 proteinThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trialThe Lancet, 2002
- Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial IschemiaCirculation, 2002
- Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina PectorisCirculation, 2002
- Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2Circulation, 2002
- Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1αPhysiological Genomics, 2002
- Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass SurgeryCirculation, 1999